Publications
Goodwin PJ, Ballman KV, Small EJ, Cannistra SA. Evaluation of treatment benefit in Journal of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013. PMID: 23358984
Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nature cell biology. 2013. PMID: 23354167
Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science (New York, N.Y.). 2013. PMID: 23348506
Hu S, Xu-Monette ZY, Balasubramanyam A, Manyam GC, Visco C, Tzankov A, Liu WM, Miranda RN, Zhang L, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, Han van Krieken J, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Zhao X, Winter JN, Zhang M, Li L, Møller MB, Piris MA, Li Y, Go RS, Wu L, Medeiros LJ, Young KH. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2013. PMID: 23343832
Tempero MA, Klimstra D, Berlin J, Hollingsworth T, Kim P, Merchant N, Moore M, Pleskow D, Wang-Gillam A, Lowy AM. Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013. PMID: 23344262
Kaushik S, Teque F, Patel M, Fujimura SH, Schmidt B, Levy JA. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state. AIDS research and human retroviruses. 2013. PMID: 23131038
Van Loon K, Wigler D, Niedzwiecki D, Venook AP, Fuchs C, Blanke C, Saltz L, Goldberg RM, Meyerhardt JA. Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405. Clinical colorectal cancer. 2013. PMID: 23317558
Chari A, Pri-Chen H, Jagannath S. Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma. Clinical lymphoma, myeloma & leukemia. 2013. PMID: 23313067
Ippolito G, Levy JA, Sonnerborg A, Mugusi F, Dianzani F. AIDS and HIV Infection after Thirty Years. AIDS research and treatment. 2013. PMID: 23365727
Smith CC, Shah NP. The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714533
Biran N, Jagannath S, Chari A. Risk stratification in multiple myeloma, part 2: the significance of genetic risk factors in the era of currently available therapies. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24518521
Venook AP, Saltz LB. Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714476
GBD 2010 Country Collaboration. The Lancet GBD 2010 Country Results: a Global Public Good. 2013. PMID:
Kaplan LD. Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Volume 2013 Hematology. American Society of Hematology. Education Program. 2013. PMID: 24319170
Shah SK, Hull SC, Spinner MA, Berkman BE, Sanchez LA, Abdul-Karim R, Hsu AP, Claypool R, Holland SM. What does the duty to warn require? The American journal of bioethics : AJOB. 2013. PMID: 24024817
Vahdat LT, Rugo HS, Perez EA. New developments in metastatic breast cancer: general discussion. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24765684
Perez EA, Rugo HS, Vahdat LT. New developments in metastatic breast cancer: integrating recent data into clinical practice. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24892840
Ang CS, Kelley RK, Choti MA, Cosgrove DP, Chou JF, Klimstra D, Torbenson MS, Ferrell L, Pawlik TM, Fong Y, O'Reilly EM, Ma J, McGuire J, Vallarapu GP, Griffin A, Stipa F, Capanu M, Dematteo RP, Venook AP, Abou-Alfa GK. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointestinal cancer research : GCR. 2013. PMID: 23505572
Rugo HS. New developments in metastatic breast cancer: introduction. Clinical advances in hematology & oncology : H&O. 2013. PMID: 24637554
Kelley RK, Venook AP. Novel therapeutics in hepatocellular carcinoma: how can we make progress? American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2013. PMID: 23714481